Company profile · Warsaw, Poland

URPL Poland

Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance · National registration authority

Verified 15 Mar 2026 · 3 sources

PolandRegulatory anchorWarsaw

National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.

Lead
Grzegorz Cessak (verified ↗)
Compliance
Not yet on record
Last reviewed
15 Mar 2026 (4mo ago)
Scale
National registration authority
Capabilities
Registration of medicinal products · Medical-device oversight · Biocidal product regulation
Founded
2002
Headcount
201-500
Editorial note

Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance

National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.

Related companies
Editorial note

URPL anchors the Polish regulatory layer for approvals, market access, vigilance, and regulated product governance.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 15 March 2026

Verification details

Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Grzegorz Cessak

President

Check official leadership source
Full addressAl. Jerozolimskie 181C, 02-222 Warszawa, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official URPL contact page listing Al. Jerozolimskie 181C in Warsaw.

Open source
Operating profile

National registration authority

Warsaw, Poland. Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance. Review completed on 15 Mar 2026.

2026 technical specializationMedicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance
Core capabilities
Registration of medicinal productsMedical-device oversightBiocidal product regulationPost-market vigilance
Governance

Polish Ministry of Health and EU medicines regulatory framework

National registration authority, EU medicines and devices regulatory enforcement

Capabilities

Registration of medicinal products
Medical-device oversight
Biocidal product regulation
Post-market vigilance

Sources

The official sources used to verify this profile.

Leadership evidenceOfficial URPL president page confirming Grzegorz Cessak.Source origin: gov.plOpen source
Supporting evidenceOfficial URPL institutional surface describing the office of registration of medicinal products, medical devices and biocidal products.Source origin: gov.plOpen source
Physical-site evidenceOfficial URPL contact page listing Al. Jerozolimskie 181C in Warsaw.Source origin: gov.plOpen source

Infrastructure

Registration offices
Assessment teams
Vigilance and device supervision systems

Certifications

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026

Review log

15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.

Frequently asked questions

Where is URPL Poland located?
URPL Poland operates from Al. Jerozolimskie 181C, 02-222 Warszawa, Poland, Warsaw, Poland.
Who runs URPL Poland?
URPL Poland is led by Grzegorz Cessak, President. Verified 15 Mar 2026.
What does URPL Poland do?
National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access. Core capabilities: Registration of medicinal products, Medical-device oversight, Biocidal product regulation, Post-market vigilance.
Editorial context

Related technical briefs

Briefs that name Warsaw as a covered market or city.